VNTA OTC
Ventana Biotech, Inc.
1W: -35.5%
1M: -35.5%
3M: -49.8%
YTD: -14.4%
1Y: +45.6%
3Y: -94.7%
5Y: -96.0%
$0.03
-0.00 (-5.11%)
Weekly Expected Move ±33.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$41K
+29.9% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
$21K
+12.6% ▲
Net Income
$20K
+15.1% ▲
EPS (Diluted)
$0.00
+33.3% ▲
EBITDA
$21K
+12.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2021 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $32K | $41K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +29.9% |
| Cost of Revenue | $0 | $0 | $0 | $32K | $41K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | 0.0% | 0.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $600 | $300 | $7K | $13K | $21K |
| Operating Expenses | $600 | $300 | $7K | $13K | $21K |
| Operating Income | -$600 | -$300 | -$7K | $18K | $21K |
| Operating Margin | — | — | — | 58.0% | 50.3% |
| Interest Expense | $3K | $5K | $75K | $0 | $33 |
| Income Before Tax | -$4K | -$5K | -$82K | $18K | $21K |
| Tax Expense | $0 | $0 | $0 | $1K | $872 |
| Net Income | -$4K | -$5K | -$82K | $17K | $20K |
| Net Margin | — | — | — | 54.3% | 48.1% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $0.00 | $0.00 |
| EBITDA | -$600 | -$300 | -$7K | $18K | $21K |
| Shares Outstanding | 5M | 5M | 32M | 54M | 54M |